Flow-injection analysis for meloxicam based on tris(2,2′-bipyridine) ruthenium(II)-Ce(IV) chemiluminescent system

Luminescence

Volumn 24, Issue 4, 2009, Pages 260-265

  Ye, Huazhen ^a,b   Qiu, Bin ^a   Chen, Jing ^a   Lin, Jinming ^a   Chen, Guonan ^a  

^a FUZHOU UNIVERSITY   (China)

^b Fujian Health College   (China)

Author keywords

Chemiluminescence; Flow injection; Meloxicam; Tris(2,2 bipyridine)ruthenium(II)

Indexed keywords

CERIUM COMPOUNDS; RUTHENIUM COMPOUNDS; SULFUR COMPOUNDS;

BIPYRIDINES; CHEMILUMINESCENCE INTENSITY; CONCENTRATION RANGES; FLOW INJECTION; FLOW INJECTION ANALYSIS; FLOW-INJECTION SYSTEM; LINEAR RELATIONSHIPS; MELOXICAM; OPTIMUM CONDITIONS; TRIS(2,2′BIPYRIDINE)RUTHENIUM(II);

CHEMILUMINESCENCE;

2,2' BIPYRIDINE; CERIUM; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; RUTHENIUM; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CHEMOLUMINESCENCE; ECONOMICS; FLOW INJECTION ANALYSIS; METHODOLOGY; SENSITIVITY AND SPECIFICITY; TABLET;

2,2'-DIPYRIDYL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CERIUM; CHEMILUMINESCENT MEASUREMENTS; FLOW INJECTION ANALYSIS; MOLECULAR STRUCTURE; RUTHENIUM; SENSITIVITY AND SPECIFICITY; TABLETS; THIAZINES; THIAZOLES;

EID: 69349099714     PISSN: 15227235     EISSN: 15227243     Source Type: Journal    
DOI: 10.1002/bio.1117     Document Type: Article

References (15)

1. Wang P, Gu ZL. A new typenon-steroidal anti-inflammatory drug-meloxicam. Chin. J. New Drugs Clin. Rem. 2000; 19(6): 499-501.
2. Wiesner JL, de Jager AD, Sutherland FCW, Hundt HKL, Swart KJ, Hundt AF, Els J. Sensitive and rapid liquid chromatography-tandem mass spectrometry method for the determination of meloxicam in human plasma. J. Chromatogr. B 2003; 785: 115-121.
3. Medvedovic A, Albu F, Georgita C, Mircioiu C, Davi V. A non-extracting procedure for the determination of meloxicam in plasma samples by HPLC-diode array detection. Arzneimitt.-Forsch. 2005; 55(6): 326- 331.
4. You WW, Liu Y, Wang ZB. Determination of meloxicam tablets by ultraviolet spectrophotometry. Chin. J. Anal. Chem. 1999; 27(7): 841-844.
5. Ekram MH. Spectrophotometric and fluorimetric methods for the determination of meloxicam in dosage forms. J. Pharm. Biomed. Anal. 2002; 27: 771-775.
6. Altinoz S, Nemutlu E, Kir S. Polarographic behavior of meoxicam and its determination in tablet preparations and spiked plasma. Farmaco 2002; 57(6): 463-468.
7. Radi A, El Ries MA, El-Anwar F, El-Sherif Z. Electrochemical oxidation of meloxicam and its determination in tablet dosage form. Anal. Lett. 2001; 34(5): 739-748.
8. Emirhan N, Sedef K. Method development and validation for the analysis of meloxicam in tablets by CZE. J. Pharm. Biomed. Anal. 2003; 31: 393-400.
9. Hopkala H, Pomykalski A. TLC analysis of inhibitors of cyclooxygenase and videodensitometric determination of meloxicam and tiaprofenic acid. J. Planar Chromatogr. Mod. TLC 2003; 16(2): 107-111.
10. Liu HY, Zhang L, Hao YH, Wang QJ, He PG, Fang YZ. Flow-injection chemiluminescence determination of meloxicam by oxidation with N-bromosuccinimide. Anal. Chim. Acta 2005; 541: 187-192.
11. Ye HZ, Chen S, Geng YY, Qiu B. Determination of meloxicam by electrochemiluminescence. Strait. Pharm. J. 2005; 117(3): 51-53.
12. 2+-isoniazid-Ce(IV) system. J. Pharm. Biomed. Anal. 2004; 36: 237-241.
13. Zhang SH, Xi J, He ZK. Detection of furosemide with tris-(2,2′-bipy-ridyl) ruthenium-Ce() chemiluminescence system. Chin. J. Anal. Chem. 2005; 33(9): 1269-1271.
14. Gerardi RD, Barnett NW, Lewis SW. Analytical applications of tris(2,2′- bipyridyl)ruthenium(III) as a chemiluminescent reagent. Anal. Chim. Acta 1999; 378: 1-41.
15. Alarfaj NA, Abd El-Razeq SA. Flow-injection chemiluminescent determination of cefprozil using tris (2,2′-bipyridyl) ruthenium (II)-permanganate system. J. Pharm. Biomed. Anal. 2006; 41: 1423-1427.